Attached files
Exhibit 16.1
October 10, 2011
U.S. Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549
RE: Puma Biotechnology, Inc.
File No.: 000-52811
We have read the statements under Item 4.01 of the Current Report on Form 8-K to be filed with the Securities and Exchange Commission on October 10, 2011 regarding the change of auditors. We agree with all statements pertaining to us.
We have no basis to agree or disagree with statements pertaining to the successor accountants.
/s/ MaloneBailey, LLP
www.malone-bailey.com
Houston, Texas